Delivery Order SPE2DB22D2005-SPE2DB25FJKK5
Award Date
3/28/25
Potential Completion Date
3/31/25
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,211.13 delivery order contract is for the supply of 4559304324 - Clindamycin PH 1% Gel 30GM, with a completion date of December 8, 2022. The contract has a firm fixed price pricing type and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,349.84 firm fixed-price delivery order (SPE2DB20D1109|SPE2DB24FP90Y) is for the supply of Clindamycin Phosphate 1% Gel, a topical antibiotic medication. The contract has an ultimate completion date of September 17, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,617.13 fixed-price delivery order is for the supply of Clindamycin 1% Gel, 30 grams, to support military healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary...
This federal contract award, valued at $1,141.84, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Clindamycin PH 1% gel, a pharmaceutical product, with a completion date of February 12, 2024. The contract is a firm-fixed-price type and does not have a set-aside designation, indicating it was awarded through full and open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,700.58, is for the delivery of 4557677832 (Clindamycin PH 1% Gel 30GM) and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,213.78 Firm Fixed Price Delivery Order is for the supply of Clindamycin Phosphate 1% Gel, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of December 20, 2023 and was awarded on December 19, 2023 with no set-aside designation. Amerisourcebergen Drug Corp holds a larger $999,999,999...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, to provide Clindamycin PH 1% gel in 30 gram quantities. The contract has a ceiling value of $1,381.15 and a period of performance through April 4, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Clindamycin 1% Gel, a pharmaceutical product, with a total ceiling value of $1,509.40 and a final completion date of September 21, 2023. The contract is not designated as a set-aside and was awarded through full and open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,888.43 firm fixed-price contract is for the supply of Clindamycin Phosphate 1% gel, a topical antibiotic medication. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA's Troop Support Medical division, valued at $999,999,999 and running through November 2026. The IDC serves as a...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,064 firm-fixed-price delivery order is for the supply of Clindamycin Phosphate 1% Lotion, a topical antimicrobial medication. The contract has an ultimate completion date of September 19, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...